atomoxetine sandoz 40 mg
sandoz - københavn - atomoksetinhydroklorid - kapsel, hard - 40 mg
atomoxetine sandoz 60 mg
sandoz - københavn - atomoksetinhydroklorid - kapsel, hard - 60 mg
atomoxetine sandoz 80 mg
sandoz - københavn - atomoksetinhydroklorid - kapsel, hard - 80 mg
givlaari
alnylam netherlands b.v. - givosiran - porfyrier, nedsatt - ulike alimentary tract and metabolism products - behandling av akutt hepatisk porfyri (ahp) i voksne og ungdom i alderen 12 år og eldre.
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - legemidler for obstruktive sykdommer i luftveiene, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - legemidler for obstruktive sykdommer i luftveiene, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
oxlumo
alnylam netherlands b.v. - lumasiran sodium - hyperoxaluria, primary - andre alimentary tract and metabolism products, - treatment of primary hyperoxaluria type 1 (ph1) in all age groups.
vaxzevria (previously covid-19 vaccine astrazeneca)
astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vaksiner - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger.
enspryng
roche registration gmbh - satralizumab - neuromyelitis optica - immunsuppressive - satralizumab (enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (ist) for the treatment of neuromyelitis optica spectrum disorders (nmosd) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 igg (aqp4-igg) seropositive.
calcipotriol/betamethasone aristo 50 mikrog/ g / 0.5 mg/ g
aristo pharma gmbh - kalsipotriolmonohydrat / betametasondipropionat - gel - 50 mikrog/ g / 0.5 mg/ g